[SYRE] QoQ Quarter Result on 30-Sep-2016 [#Q3]

Stock
[SYRE] Spyre Therapeutics, Inc.
Announcement Date
30-Sep-2016
Financial Year
2016
Quarter
30-Sep-2016 [#Q3]
Profit Trend
QoQ- -14.88%
YoY- -82.77%
Quarter Report
SYRE's Result
SYRE's Financial Summary
View:
Show?
Quarter Result
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Revenue 1,479 982 1,247 1,149 1,373 859 1,585 -4.51%
PBT -6,632 -6,247 -5,483 -6,238 -5,430 -4,547 -3,987 40.43%
Tax 0 0 0 0 0 0 0 -
NP -6,632 -6,247 -5,483 -6,238 -5,430 -4,547 -3,987 40.43%
Tax Rate - - - - - - - -
Total Cost 8,111 7,229 6,730 7,387 6,803 5,406 5,572 28.47%
Ratio Analysis
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
NP Margin -448.41 -636.15 -439.70 -542.91 -395.48 -529.34 -251.55 47.06%
Per Share
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
EPS -11.75 -11.68 0.00 -11.70 -11.53 -9.95 0.00 -
EPS Diluted -11.75 -11.68 0.00 -11.70 -11.53 -9.95 0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.